|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Liver Retransplantation in HIV‐Infected Patients: A Prospective Cohort Study显示文摘 | M. Gastaca F. Aguero A. Rimola M. Montejo P. Miralles R. Lozano L. Castells M. Abradelo M. de la Mata F. San Juan Rodríguez E. Cordero S. del Campo C. Manzardo J.O. de Urbina I. Pérez G. de la Rosa J. M. Miro | 2012 | American Journal of Transplantation2012，，9： | 2 |
| 2 | 'Very early' intrahepatic cholangiocarcinoma in cirrhotic patients:should liver transplantation be reconsidered in these patients?显示文摘 | Sapisochin G Rodriguez de Lope C Gastaca M | 2014 | Am J transplant2014，14，3： | 1 |
| 3 | Minimally invasive liver resection for huge(≥10cm)tumors:an international multicenter matched cohort study with regression discontinuity analyses显示文摘Background:The application and feasibility of minimally invasive liver resection(MILR)for huge liver tumours(≥10 cm)has not been well documented.Methods:Retrospective analysis of data on 6,617 patients who had MILR for liver tumours were gathered from 21 international centers between 2009-2019.Huge tumors and large tumors were defined as tumors with a size≥10.0 cm and 3.0-9.9 cm based on histology,respectively.1:1 coarsened exact-matching(CEM)and 1:2 Mahalanobis distance-matching(MDM)was performed according to clinically-selected variables.Regression discontinuity analyses were performed as an additional line of sensitivity analysis to estimate local treatment effects at the 10-cm tumor size cutoff.Results:Of 2,890 patients with tumours≥3 cm,there were 205 huge tumors.After 1:1 CEM,174 huge tumors were matched to 174 large tumors;and after 1:2 MDM,190 huge tumours were matched to 380 large tumours.There was significantly and consistently increased intraoperative blood loss,frequency in the application of Pringle maneuver,major morbidity and postoperative stay in the huge tumour group compared to the large tumour group after both 1:1 CEM and 1:2 MDM.These findings were reinforced in RD analyses.Intraoperative blood transfusion rate and open conversion rate were significantly higher in the huge tumor group after only 1:2 MDM but not 1:1 CEM.Conclusions:MILR for huge tumours can be safely performed in expert centers It is an operation with substantial complexity and high technical requirement,with worse perioperative outcomes compared to MILR for large tumors,therefore judicious patient selection is pivotal. | Tan-To Cheung Xiaoying Wang Mikhail Efanov Rong Liu David Fuks Gi-Hong Choi Nicholas LSyn Charing CChong Iswanto Sucandy Adrian KHChiow Marco VMarino Mikel Gastaca Jae Hoon Lee TPeter Kingham Mathieu D’Hondt Sung Hoon Choi Robert PSutcliffe Ho-Seong Han Chung Ngai Tang Johann Pratschke Roberto ITroisi Brian KPGoh International Robotic and Laparoscopic Liver Resection Study Group Collaborators | 2021 | Hepatobiliary Surgery and Nutrition2021，10，5： | 1 |
| 4 | Biliary complications in orthotopic liver transplantation using choledochocholedochostomy with a T-tube显示文摘 | Gastaca M Matarranz A Mu(n)oz F | 2012 | Transplantation Proceedings2012，，06： | 1 |
| 5 | Reducing the incidence of incisional hernia 'after liver transplantation显示文摘 | Gastaca M Valdivieso A Ruiz P | 2010 | Transpl lnt2010，23，5： | 1 |
| 6 | Donors older than 70 years in liv- er transplantation 显示文摘 | Gastaca M Valdivieso A Pjoan J | 2005 | Transplant Proc2005，，37： | 1 |
| 7 | Extended criteria donors in liver transplantation: adapting donor quality and recipient显示文摘 | Gastaca M | 2009 | Transplant Proc2009，41，3： | 1 |
| 8 | Biliary Complications in Orthotopic Liver Transplantation Using Choledochocholedochostomy with a T-tube显示文摘 | M. Gastaca A. Matarranz F. Mu?oz A. Valdivieso A. Aguinaga M. Testillano J. Bustamante I. Terreros M.J. Suarez M. Montejo J. Ortiz de Urbina | 2012 | Transplantation Proceedings2012，，6： | 1 |
| 9 | Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study显示文摘 | Sapisochin G de Lope CR Gastaca M | 2014 | Ann Surg2014，259，5： | 1 |
| 10 | Biliary complications after orthotopic livertransplantation : a review of incidence and risk factors 显示文摘 | Gastaca M | 2012 | Transplant Proc2012，44，6： | 1 |
| 11 | Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation显示文摘 | A. Valdivieso J. Bustamante M. Gastaca J.G. Uriarte A. Ventoso P. Ruiz J.R. Fernandez I. Pijoan M. Testillano M.J. Suarez M. Montejo J. Ortiz de Urbina | 2010 | Transplantation Proceedings2010，，2： | 1 |
| 12 | Extended criteria donors in liver transplantation:adapting donor quality and recipient 显示文摘 | Gastaca M | 2009 | Trans-plant Proc2009，41，3： | 1 |
| 13 | Biliary Complications after Orthotopic Liver Transplantation: A Review of Incidence and Risk Factors显示文摘 | M. Gastaca | 2012 | Transplantation Proceedings2012，，： | 1 |
| 14 | “ Very Early ” Intrahepatic Cholangiocarcinoma in Cirrhotic Patients: Should Liver Transplantation Be Reconsidered in These Patients?显示文摘 | G. Sapisochin C. Rodríguez de Lope M. Gastaca J. Ortiz de Urbina M. A. Suarez J. Santoyo J. F. Castroagudín E. Varo R. López‐Andujar F. Palacios G. Sanchez Antolín B. Perez A. Guiberteau G. Blanco M. L. González‐Diéguez M. Rodriguez M. A. Varona M. A. Bar | 2014 | American Journal of Transplantation2014，，3： | 1 |
| 15 | Donors older Than 70 years in liver transplantation显示文摘 | Gastaca M Valdivieso A Pijoan J | 2005 | Transplant Prnc2005，37，9： | 1 |
| 16 | Is Antithrombotic Prophylaxis Required After Liver Transplantation in HIV‐Infected Recipients?显示文摘 | M. Gastaca A. Valdivieso M. Montejo J. Bustamante J. O. de Urbina | 2012 | American Journal of Transplantation2012，，8： | 1 |
| 17 | 'Very early' intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?显示文摘 | Sapisochin G Rodriguez de Lope C Gastaca M | 2014 | Am J Transplant2014，14，3： | 1 |
| 18 | Liver Retransplantation in Patients With HIV‐1 Infection: An International Multicenter Cohort Study显示文摘 | F. Agüero A. Rimola P. Stock P. Grossi J. K. Rockstroh K. Agarwal C. Garzoni L. A. Barcan F. Maltez C. Manzardo M. Mari M. V. Ragni E. Anadol F. Di Benedetto S. Nishida M. Gastaca J. M. Miró | 2016 | American Journal of Transplantation2016，，2： | 1 |
| 19 | Donors older than 70 years in liver transplantation显示文摘 | Gastaca M Valdivieso A Pijoan J | 2005 | Transplant Proc2005，37，9： | 1 |
| 20 | Early tacrolimus exposure does not impact long-term outcomes after liver transplantation显示文摘BACKGROUND Tacrolimus trough levels(TTL)during the first weeks after liver transplantation(LT)have been related with long-term renal function and hepatocellular carcinoma recurrence.Nevertheless,the significance of trough levels of tacrolimus during the early post-transplant period for the long-term outcome is under debate AIM To evaluate the effect of TTL during the first month on the long-term outcomes after LT.METHODS One hundred fifty-five LT recipients treated de novo with once-daily tacrolimus were retrospectively studied.Patients with repeated LT or combined transplantation were excluded as well as those who presented renal dysfunction prior to transplantation and/or those who needed induction therapy.Patients were classified into 2 groups according to their mean TTL within the first month after transplantation:≤10(n=98)and>10 ng/mL(n=57).Multivariate analyses were performed to assess risk factors for patient mortality.RESULTS Mean levels within the first month post-transplant were 7.4±1.7 and 12.6±2.2 ng/mL in the≤10 and>10 groups,respectively.Donor age was higher in the high TTL group 62.9±16.8 years vs 45.7±17.5 years(P=0.002)whilst mycophenolate-mofetil was more frequently used in the low TTL group 32.7%vs 15.8%(P=0.02).Recipient features were generally similar across groups.After a median follow-up of 52.8 mo(range 2.8-81.1),no significant differences were observed in:Mean estimated glomerular filtration rate(P=0.69),hepatocellular carcinoma recurrence(P=0.44),de novo tumors(P=0.77),new-onset diabetes(P=0.13),or biopsy-proven acute rejection rate(12.2%and 8.8%,respectively;P=0.50).Eighteen patients died during the follow-up and were evenly distributed across groups(P=0.83).Five-year patient survival was 90.5%and 84.9%,respectively(P=0.44),while 5-year graft survival was 88.2%and 80.8%,respectively(P=0.42).Early TTL was not an independent factor for patient mortality in multivariate analyses.CONCLUSION Differences in tacrolimus levels restricted to the first month after transplant did not result in significant differences in long-term outcomes of LT recipients. | Mikel Gastaca Patricia Ruiz Javier Bustamante Lorea Martinez-Indart Alberto Ventoso JoséRamón Fernandez Ibone Palomares Mikel Prieto Milagros Testillano Patricia Salvador Maria Senosiain Maria Jesus Suárez Andres Valdivieso | 2021 | World Journal of Hepatology2021，13，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员